Wolfram's syndrome presenting as a cerebellar ataxia;Ataxie cérébelleuse révélant un syndrome de Wolfram

Revue Neurologique

Volumn 163, Issue 2, 2007, Pages 197-204

  Mathis, S ^a   Paquis, V ^b   Mesnage, V ^a   Balaboi I ^a   Gil, R ^a   Gilbert, B ^a   Neau, J P ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Cerebellar ataxia; Late diagnosis; Wolfram's syndrome

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN STEM; CASE REPORT; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; DIABETES INSIPIDUS; DIABETES MELLITUS; HEARING IMPAIRMENT; HUMAN; MALE; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE; NYSTAGMUS; PATHOLOGY; URINARY TRACT DISEASE; WOLFRAM SYNDROME;

EID: 33847301900     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(07)90391-4     Document Type: Article

References (82)

1. ABOSEIF S, GASPARINI M, SCHMIDT R, TANAGHO E. (1993). Wolfram's (DIDMOAD) syndrome and its urological manifestations. Br J Urol, 72: 106-111.
2. AL-TILL M, JARRAH NS, AJLOUNI KM. (2002). Ophtalmologic findings in fifteen patients with Wolfram syndrome. Eur J Ophtalmol, 12: 84-88.
3. BANG OY, LEE PH, KIM SY, KIM HJ, HUH K. (2004). Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis. J Neurol Neurosurg Psychiatry, 75: 1452-1456.
4. BARRETT TG. (2001). Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes. Best Pract Res Clin Endocrinol Metab, 15: 325-343.
5. BARRETT TG, BUNDEY SE, MACLEOD AF. (1995). Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet, 346: 1458-1463.
6. BARRETT TG, SCOTT-BROWN M, SELLER A, BEDNARZ A, POULTON K, POULTON J. (2000). The mitochondrial genome in Wolfram syndrome. J Med Genet, 37: 463-466.
7. BAZ P, AZAR ST, MEDLEJ R, BEJJANI R, HALABI G, SALTI I. (1999). Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care, 22: 1376-1378.
8. BERNARD C, GRANGE JD. (1987). Wolfram's or DIDMOAD's syndrome. Bull Soc Ophtalmol Fr, 87: 651-653.
9. CARELLI V, ROSS-CISNEROS FN, SADUN AA. (2002). Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int, 40: 573-584.
10. CASTRO FJ, BARRIO J, PERENA MF, PALOMAR MT, CRISTOBAL JA. (2000). Uncommon ophtalmologic findings associated with Wolfram syndrome. Acta Ophtalmol Scand, 78: 118-119.
11. CHU P, STAFF WG, MORRIS JA, POLAK JM. (1986). DIDMOAD syndrome with megacystis and megaureter. Postgrad Med J, 62: 859-863.
12. COLLIER DA, BARRETT TG, CURTIS D et al. (1996). Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity. Am J Hum Genet, 59: 855-863.
13. COLOSIMO A, GUIDA V, RIGOLI L et al. (2003). Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay. Hum Mutat, 21: 622-629.
14. COPPELLI A, GIANNARELLI R, PALUMBO F et al. (2003). Solitary pancreas transplantation in Wolfram syndrome. Transplantation, 76: 1535-1536.
15. CRAWFORD J, ZIELINSKI MA, FISHER LJ, SUTHERLAND GR, GOLDNEY RD. (2002). Is there a relationship between Wolfram syndrome carrier status and suicide? Am J Med Genet, 114: 343-346.
16. CREMERS CW, WIJDEVELD PG, PINCKERS AJ. (1977). Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder and other abnormalities (Wolfram syndrome). Acta Paediatr Scand Suppl, 264: 1-16.
17. CRYNS K, SIVAKUMARAN TA, VAN DEN OUWELAND JM et al. (2003). Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum Mutat, 22: 275-287.
18. DELBELLO MP, STRATOWSKI SM, ZIMMERMAN ME, HAWKINS JM, SAX KW. (1999). MRI analysis of the cerebellum in bipolar disorder: a pilot study. Neuropsychopharmacology, 21: 63-68.
19. DIMAURO S. (2004). Mitochondrial diseases. Biochim Biophys Acta, 1658(1-2): 80-8.
20. DOMÈNECH E, KRUYER H, GÓMEZ C, CALVO MT, NUNES V. (2004). First prenatal diagnosis for Wolfram syndrome by molecular analysis of the WFS1 gene. Prenat Diagn, 24: 787-789.
21. DREYER M, RUDIGER HW, BUJARA K et al. (1982). The syndrome of diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and other abnormalities (DIDMOAD-syndrome). Klin Wochenschr, 60: 471-475.
22. ELLER P, FÖGER B, GANDER R et al. (2001). Wolfram syndrome: a clinical and molecular genetic analysis. J Med Genet, 38: 37-41.
23. EL-SHANTI H, LIDRAL AC, JARRAH N, DRUHAN L, AJLOUNI K. (2000). Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q. Am J Hum Genet, 66: 1229-1236.
24. EVANS KL, LAWSON D, MEITINGER T, BLACKWOOD DH, PORTEOUS DJ. (2000). Mutational analysis of the Wolfram syndrome gene in two families with chromosome 4p-linked bipolar affective disorder. Am J Med Genet, 96: 158-160.
25. FABBRI LP, NUCERA M, GRIPPO A et al. (2005). Wolfram syndrome. How much could knowledge challenge the fate? A case report. Med Sci Monit, 11: CS40-CS44.
26. FRASER F, GUNN T. (1977). Diabetes mellitus, diabetes insipidus, and optic atrophy. An autosomal recessive syndrome? J Med Genet, 14: 190-193.
27. FURLONG RA, HO LW, RUBINSZTEIN JS et al. (1999). A rare coding variant within the wolframin gene in bipolar and unipolar affective disorder cases. Neurosci Lett, 277: 123-126.
28. GABREËLS BA, SWAAB DF, KLEIJN DPV et al. (1998). The vasopressine precursor is not processed in the hypothalamus of Wolfram syndrome patients with diabetes insipidus: evidence for the involvement of PC2 and 7B2. J Clin Endocrinol Metab, 83: 4026-4033.
29. GALLUZZI P, FILOSOMI G, VALLONE IM, BARDELLI AM, VENTURI C. (1999). MRI of Wolfram syndrome (DIDMOAD). Neuroradiology, 41: 729-731.
30. GIULIANO F, BANNWARTH S, MONNOT S et al. (2005). Wolfram syndrome in French Population: characterization of novel mutations and polymorphisms in the WFS1 gene. Hum Mutat, 25: 99-100.
31. GOMEZ-ZAERA M, STROM TM, RODRIGUEZ B, ESTIVILL X, MEITINGER T, NUNES V. (2001). Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Mol Genet Metab, 72: 72-81.
32. GREGORIOS JB. (1989). Wolfram's syndrome with schizophrenia and central hypoventilation: a neurological study. J Neuropathol Exp Neurol, 48: 308-310.
33. GUNN T, BORTOLUSSI R, LITTLE J, ANDERMANN F, CLARKE FC, BELMONTE M. (1976). Juvenile diabetes mellitus, optic atrophy, sensory nerve deafness, and diabetes insipidus: a syndrome. J Paediatr, 89: 565-570.
34. HARDY C, KHANIM F, TORRES R et al. (1999). Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet, 65: 1279-1290.
35. HATTORI H, INADA H, TANAKA K et al. (1998). Auditory brainstem responses (ABR) in patients with Wolfram syndrome. No To Hattatsu, 30: 387-393.
36. HOFMANN S, BEZOLD R, JAKSCH M et al. (1997). Wolfram (DIDMOAD) syndrome and Leber hereditary optic neuropathy (LHON) are associated with distinct mitochondrial DNA haplotypes. Genomics, 39: 8-18.
37. HOFMANN S, PHILBROOK C, GERBITZ KD, BAUER MF. (2003). Wolfram syndrome: structural and functional analyses of mutant and wildtype wolframin, the WFS1 gene product. Hum Mol Genet, 12(16): 2003-2012.
38. INOUE H, TANIZAWA Y, WASSON J et al. (1998). A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet, 20: 143-148.
39. INOUKAI K, AWATA T, INOUE K et al. (2005). Identification of a novel WFS1 mutation (AFF344-345ins) in Japanese patients with Wolfram syndrome. Diabetes Res Clin Pract, 69: 136-141.
40. ISHIHARA H, TAKEDA S, TAMURA A et al. (2004). Disruption of the WFS1 gene in mice causes progressive β-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet, 13: 1159-1170.
41. KABAKUS N, CITAK KURT NA, KURT A, YILDIRIM H, YILMAZ T, AKARSU S. (2005). Additional distinct findings in three cases with Wolfram syndrome. Turk Med Sci, 35: 51-55.
42. KAPLAN J. (2002). Spinocerebellar ataxias due to mitochondrial defects. Neurochem Int, 40: 553-557.
43. KHANIM F, KIRK J, LATIF F, BARRETT TG. (2001). WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat, 17: 357-367.
44. KOBAYASHI Z, TSUNEMI T, MIAKE H, TANAKA S, WATABIKI S, MOROKUMA Y. (2005). A mother and a child with maternally inherited diabetes and deafness (MIDD) showing atrophy of the cerebrum, cerebellum and brainstem on magnetic resonance imaging (MRI). Intern Med, 44: 328-331.
45. LEIVA-SANTANA C, CARRO-MARTINEZ A, MONGES-ARGILES A, PALAO-SANCHEZ A. (1993). Neurologic manifestations in Wolfram's syndrome. Rev Neurol (Paris), 149: 26-29.
46. LIM MC, THAI AC. (1990). A Chinese family with Wolfram syndrome presenting with rapidly progressing diabetic retinopathy and renal failure. Ann Acad Med Singapore, 19: 548-555.
47. MAN PY, TURNBULL DM, CHINNERY PF. (2002). Leber hereditary optic neuropathy. J Med Genet, 39: 162-169.
48. MARTORELL L, GÓMEZ ZAERA M, VALERO J et al. (2003). The WFS1 (Wolfram syndrome 1) is not a major susceptibility gene for the development of psychiatric disorders. Psychiatr Genet, 13: 29-32.
49. MCBAIN SC, MORGAN NG. (2003). Functional effects of expression of wolframin-antisense transcripts in BRIN-BD11 β-cells. Biochem Biophys Res Commun, 307: 684-688.
50. MEDLEJ R, WASSON J, BAZ P et al. (2004). Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population. J Clin Endocrinol Metab, 89: 1656-1661.
51. MEGIGHIAN D, SAVASTANO M. (2004). Wolfram syndrome. Int J Pediatr Otorhinolaryngol, 68: 243-247.
52. MIDDLE F, JONES I, MCCANDLESS F et al. (2000). Bipolar disorder and variation at a common polymorphism (A1832G) within exon 8 of the Wolfram gene. Am J Med Genet, 96: 154-157.
53. OSMAN AA, SAITO M, MAKEPEACE C, PERMUTT MA, SCHLESINGER P, MUECKLER M. (2003). Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium. J Biol Chem, 278: 52755-52762.
54. PAGE MM, ASMAL AC, EDWARDS CR. (1976). Recessive inheritance of diabetes: the syndrome of diabetes insipidus, diabetes mellitus, optic atrophy and deafness. Q J Med, 45: 505-520.
55. PAKDEMIRLI E, KARABULUT N, BIR LS, SERMEZ Y. (2005). Cranial magnetic resonance imaging of Wolfram (DIDMOAD) syndrome. Australas Radiol, 49: 189-191.
56. PAYNE M, YANG Z, KATZ BJ et al. (2004). Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophtalmoplegia: a syndrome caused by a missense mutation in OPA1. Am J Ophtalmol, 138: 749-755.
57. PEDEN NR, GAY JD, JUNG RT, KUWAYTI K. (1986). Wolfram (DIDMOAD) syndrome: a complex long-term problem in management. Q J Med, 58: 167-180.
58. PILZ D, QUARRELL OW, JONES EW. (1994). Mitochondrial mutation commonly associated with Leber's hereditary optic neuropathy observed in a patient with Wolfram syndrome (DIDMOAD). J Med Gen, 31: 328-330.
59. POLYMEROPOULOS MH, SWIFT RG, SWIFT M. (1994). Linkage for the gene of Wolfram syndrome to markers on the short arm of chromosome 4. Nat Genet, 8: 95-97.
60. RANDO TA, HORTON JC, LAYZER RB. (1992). Wolfram syndrome: evidence of a diffuse neurodegenerative disease by magnetic resonance imaging. Neurology, 42: 1220-1224.
61. REYNIER P, AMATI-BONNEAU P, VERNY C et al. (2003). OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet, 41: e110.
62. th edition. Baltimore: Williams and Wilkins; pages 43-67.
63. RUGOLO S, MIRABELLA D, PALUMBO MA, CHIANTELLO R, FIORE G. (2002). Complete Wolfram's syndrome and successful pregnancy. Eur J Obstet Gynecol Reprod Biol, 105: 192-193.
64. SAM W, QIN H, CRAWFORD B, YUE D, YU S. (2001). Homozygosity for a 4-bp deletion in a patient with Wolfram syndrome suggesting possible phenotype and genotype correlation. Clin Genet, 59: 136-138.
65. SCOLDING NJ, KELLAR-WOOD HF, SHAW C, SHNEERSON JM, ANTOUN N. (1996). Wolfram syndrome: hereditary diabetes mellitus with brainstem and optic atrophy. Ann Neurol, 39: 352-360.
66. SEQUEIRA A, KIM C, SEGUIN M et al. (2003). Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior. Am J Med Genet B Neuropsychiatr Genet, 119: 108-113.
67. SHANNON P, BECKER L, DECK J. (1999). Evidence of widespread axonal pathology in Wolfram syndrome. Acta Neuropathol (Berl), 98: 304-308.
68. SMITH CJ, CROCK PA, KING BR, MELDRUM CJ, SCOTT RJ. (2004). Phenotype-genotype correlations in a series of Wolfram syndrome families. Diabetes Care, 27: 2003-2009.
69. SOLIMAN AT, BAPPAL P, DARWISH A, RAJAB A, ASFOUR M. (1995). Growth hormone deficiency and empty sella in DIDMOAD syndrome: an endocrine study. Arch Dis Child, 73: 251-253.
70. STROM TM, HORTNAGEL K, HOFMANN S et al. (1998). Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet, 7: 2021-2028.
71. SUZUKI Y, HATA T, MIYAOKA H et al. (1996). Diabetes with the 3243 mitochondrial tRNALeu(UUR) mutation. Characteristic neuroimaging findings. Diabetes Care, 19: 739-743.
72. SWIFT RG, SADLER DB, SWIFT M. (1990). Psychiatric findings in Wolfram syndrome homozygotes. Lancet, 336: 667-669.
73. SWIFT RG, POLYMEROPOULOS MH, TORRES R, SWIFT M. (1998). Predisposition of Wolfram syndrome heterozygotes to psychiatric illness. Mol Psychiatry, 3: 86-91.
74. SWIFT M, SWIFT RG. (2000). Psychiatric disorders and mutations at the Wolfram syndrome locus. Biol Psychiatry, 47: 787-793.
75. SWIFT M, SWIFT RG. (2005). Wolframin mutations and hospitalization for psychiatric illness. Mol Psychiatry, 10: 799-803.
76. TAKEDA K, INOUE H, TANIZAWA Y et al. (2001). WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet, 10: 477-484.
77. TAKESHIMA T, NAKASHIMA K. (2005). MIDD and MELAS: a clinical spectrum. Intern Med, 44: 276-277.
78. TESSA A, CARBONE I, MATTEOLI MC et al. (2001). Identification of novel WFS1 mutations in Italian children with Wolfram syndrome. Hum Mutat, 17: 348-349.
79. THOMPSON CJ, CHARLTON J, WALFORD S et al. (1989). Vasopressin secretion in DIDMOAD (Wolfram) syndrome. Q J Med, 71: 333-345.
80. VAN DEN OUWELAND JM, CRYNS K, PENNINGS RJ et al. (2003). Molecular characterization of WFS1 in patients with Wolfram syndrome. J Mol Diagn, 5: 88-95.
81. WOLFRAM DJ, WAGENER HP. (1938). Diabetes mellitus and simple optic atrophy among siblings: report of four cases. Mayo Clin Proc, 13: 715-718.
82. YAMAGUCHI S, ISHIHARA H, TAMURA A et al. (2004). Endoplasmic reticulum stress and N-glycosylation modulate expression of WFS1 protein. Biochem Biophys Res Commun, 325: 250-256.